C1qatm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
C1qatm1c(EUCOMM)Wtsi |
Name: |
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6108260 |
Synonyms: |
C1qaFL |
Gene: |
C1qa Location: Chr4:136623228-136626114 bp, - strand Genetic Position: Chr4, 69.05 cM
|
Alliance: |
C1qatm1c(EUCOMM)Wtsi page
|
IMPC: |
C1qa gene page |
|
Mutant Cell Line: |
EPD0618_1_B03 |
Germline Transmission: |
Earliest citation of germline transmission:
J:240681
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at a position on Chromosome 4 upstream of exon 3 of the gene. The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted in the 3' untranslated region of exon 3. Flp-mediated recombination removed the FRT-flanked lacZ and neo cassette.
(J:155845)
|
|
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
10 reference(s) |
|